Clinical Significance of Early Echocardiographic Changes after Resuscitated Out-of-Hospital Cardiac Arrest.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
03 2022
Historique:
received: 21 08 2021
revised: 26 11 2021
accepted: 12 12 2021
pubmed: 20 12 2021
medline: 26 3 2022
entrez: 19 12 2021
Statut: ppublish

Résumé

Left Ventricular Systolic Dysfunction (LVSD) is common after out-of-hospital cardiac arrest (OOHCA) and can manifest globally or regionally, although its clinical significance has not been robustly studied. This study evaluates the association between LVSD, extent of coronary artery disease (CAD) and outcome in those undergoing early echocardiography and coronary angiography after OOHCA. Trans-thoracic echocardiography (TTE) was performed in OOHCA patients on arrival to our centre between May 2012 and December 2017. Rates of cardiogenic shock and extent of CAD, respectively classified by SCAI grade and the SYNTAX score, were measured. The primary end-point was 12-month mortality. From 398 patients in the King's Out of Hospital Cardiac Arrest Registry (KOCAR), 266 patients (median age 61 [53-71], 76% male) underwent both TTE and coronary angiography on arrival. 96 patients (36%) had significant LVSD (Left Ventricular Ejection Fraction [LVEF] <40%) and 139 (52.2%) patients had regional wall motion abnormalities (RWMAs). Patients with LVEF <40% had more SCAI grade C-E shock (65.3% vs. 34.5%, p <0.001) and higher 12-month mortality (55.2% vs 31.8%, p <0.001) which was more likely to be due to a cardiac aetiology (27.3% vs 5.3%, p <0.001). Patients with RWMAs had higher median SYNTAX scores (14.75 vs 7, p=0.001), culprit coronary lesions (83.5% vs. 45.3%, p <0.001) and lower 12-month mortality (29.5% vs 52%, p <0.001). Patients with LVEF <40% at presentation have an increased mortality, driven by cardiac aetiology death, while the presence of RWMAs is associated with a higher rate of culprit coronary lesions, representing a potentially reversible cause of the arrest, and improved survival at 1 year.

Sections du résumé

BACKGROUND
Left Ventricular Systolic Dysfunction (LVSD) is common after out-of-hospital cardiac arrest (OOHCA) and can manifest globally or regionally, although its clinical significance has not been robustly studied. This study evaluates the association between LVSD, extent of coronary artery disease (CAD) and outcome in those undergoing early echocardiography and coronary angiography after OOHCA.
METHODS
Trans-thoracic echocardiography (TTE) was performed in OOHCA patients on arrival to our centre between May 2012 and December 2017. Rates of cardiogenic shock and extent of CAD, respectively classified by SCAI grade and the SYNTAX score, were measured. The primary end-point was 12-month mortality.
RESULTS
From 398 patients in the King's Out of Hospital Cardiac Arrest Registry (KOCAR), 266 patients (median age 61 [53-71], 76% male) underwent both TTE and coronary angiography on arrival. 96 patients (36%) had significant LVSD (Left Ventricular Ejection Fraction [LVEF] <40%) and 139 (52.2%) patients had regional wall motion abnormalities (RWMAs). Patients with LVEF <40% had more SCAI grade C-E shock (65.3% vs. 34.5%, p <0.001) and higher 12-month mortality (55.2% vs 31.8%, p <0.001) which was more likely to be due to a cardiac aetiology (27.3% vs 5.3%, p <0.001). Patients with RWMAs had higher median SYNTAX scores (14.75 vs 7, p=0.001), culprit coronary lesions (83.5% vs. 45.3%, p <0.001) and lower 12-month mortality (29.5% vs 52%, p <0.001).
CONCLUSIONS
Patients with LVEF <40% at presentation have an increased mortality, driven by cardiac aetiology death, while the presence of RWMAs is associated with a higher rate of culprit coronary lesions, representing a potentially reversible cause of the arrest, and improved survival at 1 year.

Identifiants

pubmed: 34923035
pii: S0300-9572(21)00522-0
doi: 10.1016/j.resuscitation.2021.12.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-126

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dhruv Sarma (D)

King's College Hospital NHS Foundation Trust, London, UK.

Nilesh Pareek (N)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK. Electronic address: nileshpareek@nhs.net.

Ritesh Kanyal (R)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Antonio Cannata (A)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Rafal Dworakowski (R)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Ian Webb (I)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Jemma Barash (J)

King's College Hospital NHS Foundation Trust, London, UK.

Gift Emezu (G)

King's College Hospital NHS Foundation Trust, London, UK.

Narbeh Melikian (N)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Jonathan Hill (J)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Ajay M Shah (AM)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Philip MacCarthy (P)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Jonathan Byrne (J)

King's College Hospital NHS Foundation Trust, London, UK; School of Cardiovascular Medicine and Sciences, British Heart Foundation Centre of Excellence, King's College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH